— Know what they know.
Not Investment Advice
Also trades as: 0IFK.L (LSE) · $vol 0M

EDIT NASDAQ

Editas Medicine, Inc.
1W: -6.3% 1M: -19.8% 3M: +49.2% YTD: +30.2% 1Y: +62.8% 3Y: -72.0% 5Y: -92.0%
$2.76
+0.09 (+3.37%)
After Hours: $2.59 (-0.17, -6.16%)
Weekly Expected Move ±10.7%
$2 $2 $3 $3 $3
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 32 · $270.2M mcap · 97M float · 1.64% daily turnover · Short 42% of daily vol

📊 Key Metrics

TTM
$39M
Revenue
+8.0% YoY
$-109M
Net Income
+56.6% YoY
$-141M
Free Cash Flow
+34.5% YoY
82.9%
Gross Margin
-883.2%
Op. Margin
-882.4%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-134.9%
ROA-41.3%
ROIC213.2%

Valuation

P/E-2.5
P/B61.0
EV/EBITDA-1.7

Leverage

Debt/Equity2.81
Current Ratio3.54
Interest Cov.-91.8x

Quality Scores

Piotroski F2/9
Altman Z-12.21
Beneish M-1.74

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms